Search research articles
Contact Us
Filters
Showing results (391-400 of 400) with videos related to
Page
of 40
Sort By:
You have reached the last page of results.
This site can display upto 400 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research
|
August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group
K Ohnishi, M Tomonaga, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group
N Asou, K Adachi, J Tamura, et al.
Leukemia
|
July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
April 1, 1997
Case-control study of leukemia and diagnostic radiation exposure
H Yuasa, N Hamajima, R Ueda, et al.
International Journal of Hematology
|
August 14, 1999
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group
S Miyawaki, T Kobayashi, M Tanimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group
T Kobayashi, S Miyawaki, M Tanimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1983
[The clinical effects of a new antiviral 9-(2-hydroxyethoxymethyl) guanine (aciclovir) against herpes virus infections]
T Masaoka, H Shibata, I Amaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1983
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies]
T Masaoka, K Kimura, T Miyazaki, et al.
Page
of 40
Search research articles
Search
Showing results (391-400 of 400) with videos related to
Sort By:
Page
of 40
You have reached the last page of results.
This site can display upto 400 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research
|
August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group
K Ohnishi, M Tomonaga, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group
N Asou, K Adachi, J Tamura, et al.
Leukemia
|
July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
April 1, 1997
Case-control study of leukemia and diagnostic radiation exposure
H Yuasa, N Hamajima, R Ueda, et al.
International Journal of Hematology
|
August 14, 1999
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group
S Miyawaki, T Kobayashi, M Tanimoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group
T Kobayashi, S Miyawaki, M Tanimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1983
[The clinical effects of a new antiviral 9-(2-hydroxyethoxymethyl) guanine (aciclovir) against herpes virus infections]
T Masaoka, H Shibata, I Amaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1983
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies]
T Masaoka, K Kimura, T Miyazaki, et al.
Page
of 40